Trial record 4 of 584 for:    "Heart Defects, Congenital"

Fluid Balance During Closure of Atrial Septal Defect

This study is currently recruiting participants.
Verified February 2013 by Oslo University Hospital
Sponsor:
Collaborator:
University of Bergen
Information provided by (Responsible Party):
Marianne Indrebo, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01757743
First received: December 21, 2012
Last updated: February 28, 2013
Last verified: February 2013
  Purpose

This project will evaluate fluid balance and oedema formation in children with the same congenital heart disease (Atrial Septal Defect) who will either go through heart surgery with the use of Cardio Pulmonary Bypass and hypothermia or through interventional catheterization. The investigators will measure interstitial colloid osmotic pressure, distribution of proteins and cytokines. The study hypothesis is that "Oedema developed during heart surgery is caused by reduced colloid osmotic pressure gradient through the capillary membrane".


Condition
Heart Defects,Congenital
Heart Septal Defects, Atrial

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Protein Distribution and Colloid Osmotic Pressure in Children With Volume and Pressure Loading Due to Congenital Heart Defects

Resource links provided by NLM:


Further study details as provided by Oslo University Hospital:

Primary Outcome Measures:
  • Interstitial colloid osmotic pressure [ Time Frame: During surgery or interventional closure ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

Interstitial fluid Serum


Estimated Enrollment: 40
Study Start Date: February 2013
Estimated Study Completion Date: January 2017
Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Interventional closure
Interventional catheterization closure
Open Heart Surgery
Surgery for Atrial septal defect

  Eligibility

Ages Eligible for Study:   6 Months to 10 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Children with Atrial Septal Defect scheduled for interventional closure with device or surgical repair

Criteria

Inclusion Criteria:

  • The diagnosis of Atrial Septal Defect scheduled for closure
  • Informed consent

Exclusion Criteria:

  • Renal failure,
  • liver failure,
  • coexisting cardiac malformations
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01757743

Contacts
Contact: Marianne M Indrebø, MD m.m.indrebo@medisin.uio.no
Contact: Gunnar Norgård, MD, PhD gunnar.norgard@ous-hf.no

Locations
Norway
Oslo University Hospital Recruiting
Oslo, Norway
Contact: Marianne M Indrebø, MD       maindr@ous-hf.no   
Principal Investigator: Marianne M Indrebø, MD         
Sponsors and Collaborators
Oslo University Hospital
University of Bergen
Investigators
Principal Investigator: Marianne M Indrebo, MD Oslo University Hospital
  More Information

No publications provided

Responsible Party: Marianne Indrebo, MD Research fellow, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT01757743     History of Changes
Other Study ID Numbers: 063.09
Study First Received: December 21, 2012
Last Updated: February 28, 2013
Health Authority: Norway:National Committee for Medical and Health Research Ethics
Norway: Norwegian Social Science Data Services

Keywords provided by Oslo University Hospital:
Heart Septal Defects, Atrial
Oedema formation

Additional relevant MeSH terms:
Congenital Abnormalities
Heart Defects, Congenital
Heart Septal Defects
Heart Septal Defects, Atrial
Cardiovascular Abnormalities
Cardiovascular Diseases
Heart Diseases

ClinicalTrials.gov processed this record on April 17, 2014